# NatureCeuticals

Source: https://onco.cc/companies/natureceuticals/  
OnCo record `natureceuticals` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

NatureCeuticals is a Malaysia-based biotechnology company that leads 3 cancer trials in OnCo, testing the botanical medicine Nuvastatic for cancer-related fatigue in colorectal cancer and triple-negative breast cancer.

## Summary

NatureCeuticals is a Malaysian clinical-stage company developing standardised botanical medicines for supportive and adjunctive cancer care. Its lead product Nuvastatic, based on Orthosiphon stamineus leaf extract, is in phase 3 trials for cancer-related fatigue in patients receiving chemotherapy for colorectal and triple-negative breast cancer. On ClinicalTrials.gov it is the lead sponsor of 3 trials recorded in OnCo (3 in phase 3 or 2/3): NCT07669454 (phase 3, A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III...), NCT07669519 (phase 3, Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients...) and NCT07669467 (phase 3, Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Also known as: Natureceuticals Sdn Bhd
- Tags: ctgov-sponsor
- HQ: Kuala Lumpur
- Type: biotech
- Website: https://www.ncnatureceuticals.com/

## Sources

- Official website: https://www.ncnatureceuticals.com/
- ClinicalTrials.gov: trials led by NatureCeuticals: https://clinicaltrials.gov/search?lead=Natureceuticals%20Sdn%20Bhd

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- trials: [A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.](https://onco.cc/trials/nct07669454/), [Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients Undergoing First-Line Chemotherapy](https://onco.cc/trials/nct07669519/), [Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer](https://onco.cc/trials/nct07669467/)

---
JSON: https://onco.cc/api/v1/entities/natureceuticals.json